Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-7758.81%EBITDA Margin
VS
Market
Sector
Industry
History
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information
Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQERNEXA THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ERNA - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -37.86M | -7758.81% | $ 488K |
| 3/31/2025 | $ -38.93M | -7277.2% | $ 535K |
| 12/31/2024 | $ -36.12M | -6206.01% | $ 582K |
| 9/30/2024 | $ -38.98M | -6519.06% | $ 598K |
| 6/30/2024 | $ -19.61M | -12105.56% | $ 162K |
| 3/31/2024 | $ -19.9M | -17305.22% | $ 115K |
| 12/31/2023 | $ -19.93M | -29314.71% | $ 68K |
| 9/30/2023 | $ -19.23M | -37715.69% | $ 51K |
| 6/30/2023 | $ -21.34M | 0% | $ 0 |
| 3/31/2023 | $ -20.15M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -35.14%.
- Over the past 5 years, ERNEXA THERAPEUTICS INC's average EBITDA % has been -10422.5%.
- The median EBITDA % for ERNEXA THERAPEUTICS INC during this period was -7277.2%
- ERNEXA THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at -35.14%.
- The lowest EBITDA % recorded by ERNEXA THERAPEUTICS INC in the same timeframe -37715.69%
ERNEXA THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ERNEXA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -3.44M ] / Revenues [ $ 9.79M ]
(=) EBITDA % [ -35.14% ] ERNA - EBITDA Margin, Last 5 years
-37715.69%
Minimum
Sep 30, 2023
-35.14%
Maximum
Sep 30, 2020
-10422.5%
Average
-7277.2%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.33% |
| max | 97.24% |
| average | 16.2% |
| median | 14.74% |
| std | 26.73% |